Ziporyn, T. A growing industry and menace: Makeshift laboratory’s designer drugs. JAMA, 12 Dec 1986, 256 (22), 3061–3063. 486 kB. https://doi.org/10.1001/jama.1986.03380220011003
EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.
Vuckovic, S; Prostran, M; Ivanovic, M; Dosen-Micovic, L; Todorovic, Z; Nesic, Z; Stojanovic, R; Divac, N; Mikovic, Z. Fentanyl analogs: Structure-activity-relationship study. Curr. Med. Chem., 1 Jul 2009, 16 (19), 2468–2474. 211 kB. https://doi.org/10.2174/092986709788682074 #19
EMCDDA. Report on the risk assessment of methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (Carfentanil), European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2018. 1.3 MB. #Carfentanil
Burns, SM; Cunningham, CW; Mercer, SL. DARK classics in chemical neuroscience: Fentanyl. ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2428-2437. 1.4 MB. https://doi.org/10.1021/acschemneuro.8b00174 #Carfentanil
Ellis, CR; Kruhlak, NL; Kim, MT; Hawkins, EG; Stavitskaya, L. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking. PLOS ONE, 24 May 2018, 13 (5), e0197734. 5.5 MB. https://doi.org/10.1371/journal.pone.0197734 #Carfentanil
Kronstrand, R; Guerrieri, D; Vikingsson, S; Wohlfarth, A; Gréen, H. Fatal poisonings associated with new psychoactive substances. In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 495–541. 477 kB. https://doi.org/10.1007/164_2018_110 #Carfentanil
Kraemer, M; Boehmer, A; Madea, B; Maas, A. Death cases involving certain new psychoactive substances: A review of the literature. Forensic Sci. Int., 1 May 2019, 298, 186–267. 6.7 MB. https://doi.org/10.1016/j.forsciint.2019.02.021 #Carfentanil
Wilde, M; Pichini, S; Pacifici, R; Tagliabracci, A; Busardò, FP; Auwärter, V; Solimini, R. Metabolic pathways and potencies of new fentanyl analogs. Front. Pharmacol., 5 Apr 2019, 10 (238). 1.5 MB. https://doi.org/10.3389/fphar.2019.00238 #Carfentanil
Armenian, P; Vo, KT; Barr-Walker, J; Lynch, KL. Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology, 1 May 2018, 134, 121–132. 847 kB. https://doi.org/10.1016/j.neuropharm.2017.10.016 #Carfentanil
Åstrand, A; Guerrieri, D; Vikingsson, S; Kronstrand, R; Green, H. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects. Forensic Sci. Int., 1 Dec 2020, 317, 110553. 1.7 MB. https://doi.org/10.1016/j.forsciint.2020.110553 #Carfentanil
Allibe, N; Sam-Lai, NF; Willeman, T; Jourdil, J; Bartoli, M; Mallaret, M; Nemoz, B; Stanke-Labesque, F; Eysseric-Guerin, H. Norcarfentanil: Carfentanil misuse or remifentanil treatment? Forensic Toxicol., 1 Jul 2019, 37 (2), 488–495. 687 kB. https://doi.org/10.1007/s11419-019-00481-2 #Carfentanil
Ringuette, AE; Spock, M; Lindsley, CW; Bender, AM. DARK classics in chemical neuroscience: Carfentanil. ACS Chem. Neurosci., 2 Dec 2020, 11 (23), 3955–3967. 3.6 MB. https://doi.org/10.1021/acschemneuro.0c00441 #1